3f3v: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
===Kinase domain of cSrc in complex with inhibitor RL45 (Type II)=== | ===Kinase domain of cSrc in complex with inhibitor RL45 (Type II)=== | ||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_19462975}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 19462975 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_19462975}} | |||
==About this Structure== | ==About this Structure== | ||
3F3V is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3F3V OCA]. | 3F3V is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3F3V OCA]. | ||
==Reference== | |||
<ref group="xtra">PMID:19462975</ref><references group="xtra"/> | |||
[[Category: Gallus gallus]] | [[Category: Gallus gallus]] | ||
[[Category: Non-specific protein-tyrosine kinase]] | [[Category: Non-specific protein-tyrosine kinase]] | ||
Line 37: | Line 46: | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 22 20: | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 22 20:47:33 2009'' |
Revision as of 20:47, 22 July 2009
Kinase domain of cSrc in complex with inhibitor RL45 (Type II)Kinase domain of cSrc in complex with inhibitor RL45 (Type II)
Template:ABSTRACT PUBMED 19462975
About this StructureAbout this Structure
3F3V is a 2 chains structure of sequences from Gallus gallus. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Getlik M, Grutter C, Simard JR, Kluter S, Rabiller M, Rode HB, Robubi A, Rauh D. Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc. J Med Chem. 2009 Jul 9;52(13):3915-26. PMID:19462975 doi:10.1021/jm9002928
Page seeded by OCA on Wed Jul 22 20:47:33 2009